Should You Invest In These Falling Stocks? bebe stores, inc.(NASDAQ:BEBE) and Galena Biopharma Inc(NASDAQ:GALE)

Posted by Saimoon August 18, 2014 0 Comment 1007 views


New York, NY – 08/18/2014 –  HotStockGains provides investors  and traders with valuable trading strategies via text message and email. To join our free text message alerts service just text the word BREAKOUT to 555888 from your cell phone. Just text STOP to unsubscribe if you ever need to.

bebe stores, inc.(NASDAQ:BEBE) saw its value decline by 4.21% during Friday’s trading as the stock lost twelve cents to finish the day at $2.73. The stock notably traded for as little as $2.70 during the day, a new 52 week low for the company that has reached a high mark of $7.03 during the same period. That being said, bebe notably gained seventeen cents during after-hours trading to move to a value of $2.90.

On Friday, the California-based retail apparel stores company was downgraded from “Buy” to “Neutral” by Janney Montgomery Scott. The downgrade is unsurprising considering that bebe stores has seen its value decline from a three month high closing price of $4.62 on May 16th to today’s low. The company was also previously downgraded to Underperform by Zacks during the month of July.

Can bebe stores Reverse Its Current Fortunes? Click Here For A Free BEBE Analysis.

Galena Biopharma Inc(NASDAQ:GALE) also recorded a loss of value Friday. The stock fell nine cents, a 3.44% decrease in value that moved the stock to a closing price of $2.53. The Oregon-based biopharmaceutical company, which develops oncology treatments to address unmet needs during advanced cancer care, also lost an additional three cents during after-hours trading. Galena Biopharma has a market capitalization of $309.7 million and 118.03 million tradable shares.

After the markets closed Wednesday, the company reported its second quarter financial results. While Galena Biopharma reported a net revenue figure of $2.3 million for the period, the company also posted a net loss of $19.9 million, or $0.17 per basic share. This figure is $17.4 million greater than that which it posted for the first quarter of the 2014 fiscal year.

Will Galena Biopharma Recover From Its Disappointing Results Report? Receive A Free GALE Analysis.

About HotStockGains

I have a confession to make – I am not always right. Sometimes, unfortunately, I will send alerts that experience losses.

I have alerted companies that rallied 100% or even 6,000% (not even joking) in under a week. Likewise, I have alerted companies that tanked 10, 20, sometimes even as much as 30 or 40%. However overall it is about the net result that delivers profits into your portfolio.

Sign up for my free newsletter to receive market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks. If you are not satisfied, simply click unsubscribe.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.


Write Your Comment